Pistoia Alliance Conference: Collaborative R&D in Action
April, 20-21 & 23, 2021, Virtual Event
2021 will likely be another pivotal year for collaboration in life sciences R&D. Join us for our live, interactive virtual conference as we come together as a community, collaborating to solve common problems and to drive innovation across the ever-changing life sciences ecosystem.
Our three-day conference offers R&D stakeholders the opportunity to collaborate, learn and network across the pharma and life science R&D value chain and to join in discussions on key issues impacting our industry. We will be exploring themes ranging from Emerging Science & Technology and Digital Health to the application of Artificial Intelligence (AI) and Real-World Data.
You can expect:
- Inspiring keynote presentations from top pharma R&D leaders
- Interactive debates and fireside chats with industry thought leaders
- Unique networking opportunities
- Collaborative R&D in action showcase including highlights from our developing projects
Who will attend?
Senior leaders working in:
- Artificial Intelligence and Machine Learning
- Drug Discovery and Development
- Informatics and Data Management
- Patient Centricity and Digital Health
Conference Sponsors
Become a Sponsor
Explore our sponsor packages which offer a unique opportunity for service companies to engage with senior-level R&D leaders from leading life science institutions. If you have a service offering for this community or want to demonstrate your thought leadership, talk to Zahid Tharia about our tailored sponsorship opportunities. All our members receive a 20% discount on all opportunities and first-year members benefit from a 30% discount.
Hear from 30+ Life Science Industry Leaders
-
-
Hassan Abba
Strategy & Enterprise Architecture Lead, AstraZeneca
-
-
Gaurav Agrawal
Business Value Manager, Benchling
-
-
Dr. Steve Arlington
President, Pistoia Alliance
-
-
Rama Balakrishnan
Biomedical Ontology Specialist, Genentech
-
-
Ryan Brinkman, PhD
Managing Director, Cytapex Bioinformatics
-
-
Edwin Cohen
Digital Health R&D, AstraZeneca
-
-
Kevin Cramer
Founder & Chief Scientist, Sapio Sciences LLC
-
-
Jack DeCicco, EHS Manager Dangerous Goods Shipping and Warehouse, GSK
-
-
Steve Emrick
Director, Translational Informatics / Digital & Innovation, US Pharmacopeia
-
-
Isabella Feierberg
Associate Principal Scientist, AstraZeneca
-
-
Julie Huxley-Jones
Vice President, Research Solutions, GSK
-
-
Lars Fogh Iversen
Senior Vice President, Global Research Technologies, Novo Nordisk
-
-
Samantha Jeschonek
Product Manager, CDD
-
-
Hassan Kadhim
Global Head of Clinical Trial Business Capabilities, Clinical Innovation, Industry Collaborations, Bristol-Myers Squibb
-
-
JP Lee
Associate Technical Director, Technical IS, NIBR
-
-
Dr. Monika Lessl
Senior Vice President, Head of Corporate R&D and Social Innovation, Bayer
-
-
Craig Lipset
Co-Chair, Decentralized Trials & Research Alliance (DTRA)
-
-
Michelle Longmire
CEO, Medable
-
-
Karen Madden
VP, Technology & Innovation, PerkinElmer
-
-
James Malone
CTO, SciBite
-
-
Helen Mathews
Deputy CEO, Cure Parkinson’s Trust
-
-
Paula de Matos
Project Manager, Pistoia Alliance
-
-
Gerhard Noelken
Project Manager, Pistoia Alliance
-
-
Manuela Pausan
Postdoc, Bayer
-
-
Isaac Rodriguez-Chavez
SVP, Scientific and Clinical Affairs, Global Center of Excellence for Decentralized Clinical Trials, PRA Health Sciences
-
-
Robin Röhm
CEO, Apheris
-
-
Martin Romacker
Senior Principal Scientist, Roche
-
-
Paula Santana
Lead Graphic Designer UI / UX, Genaiz
-
-
Sabine Schefzick
Director, Science and Clinical Analytics and Analytic Innovation (SCAAI), Pfizer
-
-
Sebastian Schmidt
Co-CEO, Metaphacts
-
-
Dr. Yugal Sharma
Senior Director, Solutions, CAS
-
-
Dana Vanderwall
Director of Biology & Preclinical IT, Bristol Myers Squibb
-
-
Dr. Martín Villalba
Applied Mathematics Expert, Bayer
-
-
Julia Wilson
Associate Director, Wellcome Sanger Institute
-
-
Michael Zimmermann
Group Leader, Structural and Computational Biology Unit, EMBL